LUSPATERCEPT – A TREATMENT FOR THALASSEMIA?
Dear Editor, Among a plethora of widespread diseases in Pakistan, β-thalassemia is the commonest genetic order. According to report published by Bloomberg stated that, about 6,000 children in Pakistan are diagnosed with this genetic disorder every year, with 6-9% carrier rate.1 Consanguinity is c...
Main Author: | Taimoor Hassan |
---|---|
Format: | Article |
Language: | English |
Published: |
Khyber Medical University
2021-09-01
|
Series: | Khyber Medical University Journal |
Subjects: | |
Online Access: | https://www.kmuj.kmu.edu.pk/article/view/21856 |
Similar Items
-
Highlights on the Luspatercept Treatment in Thalassemia
by: Yesim Aydinok
Published: (2023-02-01) -
Treating Thalassemia Patients with Luspatercept: An Expert Opinion Based on Current Evidence
by: Filomena Longo, et al.
Published: (2023-03-01) -
Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis
by: Eleftheria Hatzimichael, et al.
Published: (2022-10-01) -
Thalassemia: An overview
by: Ramesh Aggarwal, et al.
Published: (2014-01-01) -
Luspatercept‐induced reduction in transfusion requirement in α‐thalassemia
by: Nicholas Jackson, et al.
Published: (2020-07-01)